Evidence map›Paper›PMID 27408762›Full record

ReviewJournal of advanced research2016

Hematologic malignancies during pregnancy: A review.

Hossam K Mahmoud, Mohamed A Samra, Gamal M Fathy

Open access · goldAbstract readReview
In one paragraph

Review in Journal of advanced research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. [Management of patients with lymphoma in pregnancy].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
  11. Article
  12. Article
  13. Current management of gynecologic cancer in pregnancyJournal of the Turkish German Gynecological Association · 2018
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hossam K MahmoudDepartment of Medical Oncology, National Cancer Institute, Cairo University, Egypt.
Mohamed A SamraDepartment of Medical Oncology, National Cancer Institute, Cairo University, Egypt.
Gamal M FathyDepartment of Hematology and BMT, Nasser Institute for Research and Treatment, Ministry of Health, Egypt.
Cairo University · EGNasser Institute hospital · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignancy is the second most common cause of mortality in the reproductive period and it complicates up to one out of every 1000 pregnancies. When cancer is diagnosed during pregnancy, the management approach must take into consideration both the mother and her fetus. Hematologic cancers diagnosed in pregnancy are not common, resulting in paucity of randomized controlled trials. Diagnosis of such malignancies may be missed or delayed, as their symptoms are similar to those encountered during normal pregnancy. Also, many imaging studies may be hazardous during pregnancy. Management of these malignancies during pregnancy induces many treatment-related risks for mother and baby and should consider patient's preferences for pregnancy continuation. In this article, hematologic malignancies diagnosed in pregnant patients including acute leukemias, chronic myeloid leukemia, lymphomas, multiple myeloma and myeloproliferative neoplasms, will be reviewed, including diagnostic and management strategies and their impact on the pregnant patient and the developing fetus.

Indexed as

Acute leukemiasChronic myeloid leukemiaHematologic malignanciesLymphomasPregnancy

Identifiers

PMID27408762
PMCPMC4921778
OpenAlexW2252996869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.